Delivery of subunit vaccines in maize seed

Journal of Controlled Release

Volumn 85, Issue 1-3, 2002, Pages 169-180

  Lamphear, Barry J ^a   Streatfield, Stephen J ^a   Jilka, Joseph M ^a   Brooks, Christopher A ^a   Barker, Donna K ^a   Turner, Debra D ^b   Delaney, Donna E ^a   Garcia, Martin ^a   Wiggins, Barry ^a   Woodard, Susan L ^a   Hood, Elizabeth E ^a   Tizard, Ian R ^b   Lawhorn, Bruce ^b   Howard, John A ^a  

^a Prodigene Inc   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Antigen stability; Escherichia coli heat labile enterotoxin; Seed derived vaccine; Transgenic corn; Transmissible gastroenteritis virus

Indexed keywords

ANTIGEN; ESCHERICHIA COLI ENTEROTOXIN; PROTEIN; VACCINE; BACTERIAL TOXIN; ENTEROTOXIN; ENTEROTOXIN LT; ESCHERICHIA COLI PROTEIN; PLANT EXTRACT; RECOMBINANT VACCINE; SPIKE PROTEIN S, TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRUS PROTEIN;

ANIMAL FOOD; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BETA CHAIN; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG POTENCY; DRUG STABILITY; ESCHERICHIA COLI; GASTROENTERITIS; GRAIN; IMMUNE RESPONSE; IMMUNIZATION; MAIZE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT SEED; PRIORITY JOURNAL; SWINE DISEASE; ANIMAL; ANIMAL DISEASE; BAGG ALBINO MOUSE; CHEMISTRY; ENTEROBACTER INFECTION; IMMUNOLOGY; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; SWINE; TRANSGENIC PLANT; TRANSMISSIBLE GASTROENTERITIS VIRUS; VACCINATION; VIROLOGY;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL TOXINS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GASTROENTERITIS, TRANSMISSIBLE, OF SWINE; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; PLANTS, GENETICALLY MODIFIED; SEEDS; SWINE; TRANSMISSIBLE GASTROENTERITIS VIRUS; VACCINATION; VACCINES, SYNTHETIC; VIRAL PROTEINS; ZEA MAYS;

EID: 0037073630     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00282-1     Document Type: Article

References (34)

1. Van Kampen K.R. Recombinant vaccine technology in veterinary medicine. Vet. Clin. North Am. Small Anim. Pract. 31:2001;535-538.
2. Davenport L.W. Regulatory considerations in vaccine design. Pharm. Biotechnol. 6:1995;81-96.
3. Melnick J.L. Virus vaccines: principles and prospects. Bull. World Health Organ. 67:1989;105-112.
4. Melnick J.L. Viral vaccines: achievements and challenges. Acta Virol. 33:1989;482-493.
5. Del Giudice G., Pizza M., Rappuoli R. Molecular basis of vaccination. Mol. Aspects Med. 19:1998;1-70.
6. Lawrence D.N., Goldenthal K.L., Boslego J.W., Chandler D.K., La Montagne J.R. Public health implications of emerging vaccine technologies. Pharm. Biotechnol. 6:1995;43-60.
7. Daniell H., Streatfield S.J., Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6:2001;219-226.
8. Cramer C.L., Boothe J.G., Oishi K.K. Transgenic plants for therapeutic proteins: linking upstream and downstream strategies. Curr. Top. Microbiol. Immunol. 240:1999;95-118.
9. Giddings G., Allison G., Brooks D., Carter A. Transgenic plants as factories for biopharmaceuticals. Nature Biotechnol. 18:2000;1151-1155.
10. Mason H.S., Arntzen C.J. Transgenic plants as vaccine production systems. Trends Biotechnol. 13:1995;388-392.
11. Streatfield S.J., Jilka J.M., Hood E.E., Turner D.D., Bailey M.R., Mayor J.M., Woodard S.L., Beifuss K.K., Horn M.E., Delaney D.E., Tizard I.R., Howard J.A. Plant-based vaccines: unique advantages. Vaccine. 19:2001;2742-2748.
12. Mason H.S., Haq T.A., Clements J.D., Arntzen C.J. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine. 16:1998;1336-1343.
13. Modelska A., Dietzschold B., Sleysh N., Fu Z.F., Steplewski K., Hooper D.C., Koprowski H., Yusibov V. Immunization against rabies with plant-derived antigen. Proc. Natl. Acad. Sci. USA. 95:1998;2481-2485.
14. Hood E.E., Jilka J.M. Plant-based production of xenogenic proteins. Curr. Opin. Biotechnol. 10:1999;382-386.
15. Hood E.E., Witcher D.R., Maddock S., Meyer T., Baszczynski C., Bailey M.R., Flynn P., Register J., Marshall L., Bond D., Kulisek E., Kusnadi A., Evangelista R., Nikolov Z., Wooge C., Mehigh R.J., Hernan R., Kappel W.K., Ritland D., Li C.-P., Howard J.A. Commercial production of avidin from transgenic maize: Characterization of transformant, production, processing, extraction and purification. Molec. Breed. 3:1997;291-306.
16. Witcher D.R., Hood E.E., Perterson D., Bailey M., Bond D., Kusnadi A., Evangelista R., Nikolov Z., Wooge C., Mehigh R., Kappel W., Register J., Howard J.A. Commercial production of β-glucosidase (GUS): a model system for the production of proteins in plants. Molec. Breed. 4:1998;301-312.
17. Hood E.E., Kusnadi A., Nikolov Z., Howard J.A. Molecular farming of industrial proteins from transgenic maize. Adv. Exp. Med. Biol. 464:1999;127-147.
18. Streatfield S.J., Mayor J.M., Barker D.K., Brooks C., Lamphear B.J., Woodard S.L., Beifuss K.K., Vicuna D.V., Massey L.A., Horn M.E., Delaney D.E., Nikolov Z.L., Hood E.E., Jilka J.M., Howard J.A. Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Dev. Biol.-Plant. 38:2002;11-17.
19. Haq T.A., Mason H.S., Clements J.D., Arntzen C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science. 268:1995;714-716.
20. M.R. Bailey. A Model System for Edible Vaccination using Recombinant Avidin Produced in Corn Seed. Master of Science thesis. Texas A&M University, 2000.
21. Black R.E. The epidemiology of cholera and enterotoxigenic E. coli diarrheal disease. Holmgren J., Lindberg A., Mollby R. Development of Vaccines and Drugs Against Diarrhea. 11th Nobel Conference, Stockholm :1986;23-32.
22. Black R.E. Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev. Infect. Dis. 12:(Suppl. 1):1990;S73-S79.
23. Sixma T.K., Pronk S.E., Kalk K.H., Wartna E.S., van Zanten B.A., Witholt B., Hol W.G. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature. 351:1991;371-377.
24. Svennerholm A.-M., Holmgren J. Oral B-subunit whole-cell vaccines against cholera and enterotoxigenic Escherichia coli diarrhea. Ala'Aldeen D.A.A., Hormaeche C.E. Molecular and Chemical Aspects of Bacterial Vaccine Development. 1995;205-232 Wiley, Chichester.
25. Nagy B., Fekete P.Z. Enterotoxigenic Escherichia coli (ETEC) in farm animals. Vet. Res. 30:1999;259-284.
26. Laude H., Rasschaert D., Delmas B., Godet M., Gelfi J., Charley B. Molecular biology of transmissible gastroenteritis virus. Vet. Microbiol. 23:1990;147-154.
27. Saif L.J., van Cott J.L., Brim T.A. Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine. Vet. Immunol. Immunopathol. 43:1994;89-97.
28. Gomez N., Carrillo C., Salinas J., Parra F., Borca M.V., Escribano J.M. Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology. 249:1998;352-358.
29. Gomez N., Wigdorovitz A., Castanon S., Gil F., Ordas R., Borca M.V., Escribano J.M. Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch. Virol. 145:2000;1725-1732.
30. Tuboly T., Yu W., Bailey A., Degrandis S., Du S., Erickson L., Nagy E. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine. 18:2000;2023-2028.
31. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
32. Kong Q., Richter L., Yang Y.F., Arntzen C.J., Mason H.S., Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA. 98:2001;11539-11544.
33. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4:1998;607-609.
34. Tacket C.O., Mason H.S., Losonsky G., Estes M.K., Levine M.M., Arntzen C.J. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182:2000;302-305.